Dr. Sartor on Emerging Agents in Prostate Cancer

(2:13)

Dr. Sartor on the VISION Trial in mCRPC

(1:30)

Dr. Sartor Discusses Prostate Cancer Drug Combinations

(42)

Dr. Sartor on Progress for the Treatment of Prostate Cancer

(1:25)

Dr. Sartor on Promising Treatment Approaches in Prostate Cancer

(1:56)

Dr. Sartor on Recent Progress on the Molecular Front for the Treatment of Prostate Cancer

(1:36)

Dr. med. Henning Sartor über Pseudo-Hunger, künstliche Zucker und falsche Essgewohnheiten | QS24

(30:48)

Fäulnis im Darm | Dr. med. Henning Sartor | Naturmedizin | QS24 Gesundheitsfernsehen

(23:28)

Falsche Essweise führt zu innerer Vergiftung | Dr. med. Henning Sartor | Naturmedizin | QS24

(28:3)

Wie Laktat deinen Körper verätzt | Dr. med. Henning Sartor | Naturmedizin | QS24

(30:13)

Die wahren Wirkungen von Vitamin K2 | Dr. med. Henning Sartor | Naturmedizin | QS24

(22:32)

Depoimento Especial Concurso de Psicólogo do TJSP

(1:16:12)

2024 Update | Lu-177 (Pluvicto), Actinium \u0026 New #ProstateCancer AntiBody | Dr. Nat Lenzo #AlexScholz

(57:58)

FALHA DE MEMÓRIA SEMPRE É PROBLEMA, PODE ATÉ SER ALZHEIMER INICIAL

(21:25)

New study changing treatment for men with prostate cancer

(2:37)

DENDREON PROVENGE Mechanism of Action

(4:21)

Dr. Sartor on the Science of Sipuleucel-T for Prostate Cancer

(1:1econd)

Dr. Sartor Discusses Sequencing Therapies in Prostate Cancer

(2:9)

Dr. Sartor Discusses PSA Testing for Prostate Cancer

(1:52)

Dr. Sartor on Mechanism of Action and Safety of Radium-223 in mCRPC

(1:24)

Dr. Sartor on the Next Steps with Sipuleucel-T for Prostate Cancer

(51)

Dr. Sartor on Provenge in Combination with Radium-223

(1:8)

Dr. Sartor Discusses PSA Testing Guidelines

(1:24)

Dr. Sartor on the Implications of the Analysis of Sipuleucel-T in Prostate Cancer

(1:16)

Dr. Sartor on Outcomes With 177Lu-PSMA-617 After Radium-223 in mCRPC

(1:38)

Dr. Sartor on Conclusions and Future of Sipuleucel-T in Prostate Cancer

(42)

Dr. Sartor on Sipuleucel-T in CRPC

(1:18)

Dr. Oliver Sartor Discusses a New Prostate Cancer Trial Combining Radium-223 and Provenge

(47)

Dr. Sartor Discusses the Novel Agent Radium-223

(1:25)

Dr. Sartor on Patients in the ALSYMPCA Radium-223 Trial

(55)